Gilles-Eric Seralini, the French researcher who conducted the study with his colleagues said, “It is absolutely scandalous that [the EFSA] keeps secret the information on which they based their evaluation [of NK603],” he said.“In any event, we will not give them anything. We will put the information in the public domain when they do,” Seralini said in an AFP report.